Presence of somatic hypermutation and activation-induced cytidine deaminase in acute lymphoblastic leukemia L2 with t(14;18)(q32;q21)

European Journal of Haematology

Volumn 74, Issue 1, 2005, Pages 11-19

  Hardianti, Mardiah Suci ^a   Tatsumi, Eiji ^a   Syampurnawati, Meilani ^a   Furuta, Kaho ^a   Suzuki, Aya ^a   Saigo, Katsuyasu ^a   Kawano, Seiji ^a   Takenokuchi, Mariko ^a   Kumagai, Shunichi ^a   Matsuo, Yoshinobu ^b   Koizumi, Tamio ^c   Takeuchi, Makoto ^d  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

^c Hyogo Cancer Center for Adults   (Japan)

^d Department of Internal Medicine   (Japan)

Author keywords

AID; ALL l2; SHM; t(14; 18)

Indexed keywords

CYTIDINE DEAMINASE; DNA NUCLEOTIDYLEXOTRANSFERASE; IMMUNOGLOBULIN HEAVY CHAIN; RAG1 PROTEIN; RAG2 PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL LINE; CHROMOSOME TRANSLOCATION 14; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHOMA; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SOMATIC HYPERMUTATION;

BASE SEQUENCE; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; CYTIDINE DEAMINASE; CYTOSINE DEAMINASE; DNA NUCLEOTIDYLEXOTRANSFERASE; DNA, NEOPLASM; DNA-BINDING PROTEINS; GENE EXPRESSION; GENES, RAG-1; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; NUCLEAR PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; TRANSLOCATION, GENETIC;

EID: 19944432947     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2004.00338.x     Document Type: Article

References (71)

1. HORSMAN DE, GASCOYNE RD, COUPLAND RW, COLDMAN AJ, ADOMAT SA. Comparison of cytogenetic analysis, Southern analysis, and polymerase chain reaction for the detection of t(14; 18) in follicular lymphoma. Am J Clin Pathol 1995;103:472-478.
2. HUANG JZ, SANGER WG, GREINER TC, et al. The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. Blood 2002;99:2285-2290.
3. MUFTI GJ, HAMBLIN TJ, OSCIER DG, JOHNSON S. Common ALL with pre-B-cell features showing (8;14) and (14;18) chromosome translocations. Blood 1983;62:1142-1146.
4. PEGORARO L, PALUMBO A, ERIKSON J, FALDA M, GIOVANAZZO B, EMANUEL BS, ROVERA G, NOWELL PC, CROCE CM. A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia. Proc Natl Acad Sci USA 1984;81:7166-7170.
5. GLUCK WL, BIGNER SH, BOROWITZ MJ, BRENCKMAN WD Jr. Acute lymphoblastic leukemia of Burkitt's type (L3 ALL) with 8;22 and 14;18 translocations and absent surface immunoglobulins. Am J Clin Pathol 1986;85:636-640.
6. THANGAVELU M, OLOPADE O, BECKMAN E, VARDIMAN JW, LARSON RA, MC KEITHAN TW, LE BEAU MM, ROWLEY JD. Clinical, morphologic, and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t(14;18)(q32;q21) and t(8;14)(q24;q32) or t(8;22)(q24;q11). Genes Chromosomes Cancer 1990;2:147-158.
7. KRAMER MH, RAGHOEBIER S, BEVERSTOCK GC, de JONG D, KLUIN PM, KLUIN-NELEMANS JC. De novo acute B-cell leukemia with translocation t(14;18): an entity with a poor prognosis. Leukemia 1991;5:473-478.
8. BRITO-BABAPULLE V, CRAWFORD A, KHOKHAR T, LAFFAN M, MATUTES E, FAIRHEAD S, CATOVSKY D. Translocations t(14;18) and t(8;14) with rearranged bcl-2 and c-myc in a case presenting as B-ALL (L3). Leukemia 1991;5: 83-87.
9. MAROSI C, BETTELHEIM P, CHOTT A, et al. Simultaneous occurrence of t(14;18) and t(8;22) common acute lymphoblastic leukemia. Ann Hematol 1992;64:101-104.
10. NACHEVA E, DYER MJ, FISCHER P, STRANKS G, HEWARD JM, MARCUS RE, GRACE C, KARPAS A. C-MYC translocations in de novo B-cell lineage acute leukemias with t(14;18)(cell lines Karpas 231 and 353). Blood 1993;82:231-240.
11. KARSAN A, GASCOYNE RD, COUPLAND RW, SHEPHERD JD, PHILLIPS GL, HORSMAN DE. Combination of t(14;18) and a Burkitt's type translocation in B-cell malignancies. Leuk Lymphoma 1993;10:433-441.
12. VAN OOTEGHEM RB, SMIT EM, BEISHUIZEN A, LAMBRECHTS AC, VD BLIJ-PHILIPSEN M, SMILDE TJ, HAGEMEIJER A. A new B-cell line showing a complex translocation (8;14;18) and BCL2 rearrangement. Cancer Genet Cytogenet 1994;74:87-94.
13. LILLINGTON DM, MONARD S, JOHNSON PW, EVANS ML, KEARNEY LU, LISTER TA, YOUNG BD, GIBBONS B. The t(14;18) in a patient with de novo acute lymphoblastic leukemia is associated with t(8;9). Leukemia 1994;8:560-563.
14. BERGER R, FLEXOR M, LE CONIAT M, LARSEN CJ. Presence of three recurrent chromosomal rearrangements, t(2;3)(p12;q37),del(8)(q24), and t(14;18), in an acute lymphoblastic leukemia. Cancer Genet Cytogenet 1996;86:76-79.
15. NAKAMURA F, TATSUMI E, TANI K, KUMAGAI S, KOSAKA Y, SANO K, NAKAMURA H, NESUMI N, ABE T, KOIWAI O. Coexpression of cell-surface immunoglobulin (sIg), terminal deoxynucleotidyl transferase (TdT) and recombination activating gene 1 (RAG-1): two cases and derived cell lines. Leukemia 1996;10:1159-1163.
16. STAMATOULLAS A, BUCHONNET G, LEPRETRE S, LENAIN P, LENORMAND B, DUVAL C, CALLAT MP, GAULARD P, BASTARD C, TILLY H. De novo acute B cell leukemia/lymphoma with t(14;18). Leukemia 2000;14:1960-1966.
17. SAIGO K, KUMAGAI S, KOGI M, IMOTO S, HAMANO K, MORITA S, CHINZEI T, KOIZUMI T, TATSUMI E. Acute B-cell lymphoblastic leukemia with t(14;18): establishment of a new cell line. Cancer Genet Cytogenet 2003;140:174-175.
18. GREER WL, LEE CL, CALLANAN MB, ZAYED E, SADEK I. Case of acute lymphoblastic leukemia presenting with t(14;18)/BCL2, t(8;14)/cMYC, and t(1;2)/FCGR2B. Am J Hematol 2003;74:112-118.
19. YOSHIDA I, TAKEUCHI M. De novo acute lymphocytic leukemia with t(14;18) complicated by tumor lysis syndrome. J Jpn Soc Int Med 2003;92:865-867 (article in Japanese).
20. SCHATZ DG, OETTINGER MA, SCHLISSEL MS. V(D)J recombination: molecular biology and regulation. Annu Rev Immunol 1992;10:359-383.
21. SASAKI R, FUKUSHIMA M, MIURA Y, CHANG LM, BOLLUM FJ. Sensitivity and applicability of different methods for detection of terminal transferase in leukemia. Leukemia 1996;10:1377-1382.
22. YONEDA N, TATSUMI E, KAWANO S, MATSUO Y, MINOWADA J, YAMAGUCHI N. Human recombination activating gene-1 in leukemia/lymphoma cells: expression depends on stage of lymphoid differentiation defined by phenotype and genotype. Blood 1993;82:207-216.
23. ICHIHARA Y, HIRAI M, KUROSAWA Y. Sequence and chromosome assignment to 11p13-p12 of human RAG genes. Immunol Lett 1992;33:277-284.
24. KINOSHITA K, HONJO T. Linking class-switch recombination with somatic hypermutation. Nat Rev Mol Cell Biol 2001;2:493-503.
25. MURAMATSU M, SANKARANAND VS, ANANT S, SUGAI M, KINOSHITA K, DAVIDSON NO, HONJO T. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 1999;274:18470-18476.
26. GREEVE J, PHILIPSEN A, KRAUSE K, KLAPPER W, HEIDORN K, CASTLE BE, JANDA J, MARCU KB, PARWARESCH R. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. Blood 2003;101:3574-3580.
27. KLEIN U, GOOSSENS T, FISCHER M, KANZLER H, BRAEUNINGER A, RAJEWSKY K, KUPPERS R. Somatic hypermutation in normal and transformed human B cells. Immunol Rev 1998;162:261-280.
28. MATSUMOTO M, MARIATHASAN S, NAHM MH, BARANYAY F, PESCHON JJ, CHAPLIN DD. Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers. Science 1996;271:1289-1291.
29. WILLIAM J, EULER C, CHRISTENSEN S, SCHLOMCHIK MJ. Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science 2002;297:2066-2068.
30. NOPPE SM, HEIRMAN C, BAKKUS MH, BRISSINCK J, SCHOTS R, THIELEMANS K. The genetic variability of the VH genes in follicular lymphoma: the impact of the hypermutation mechanism. Br J Haematol 1999;107:625-640.
31. AARTS WM, BENDE RJ, STEENBERGEN EJ, KLUIN PM, OOMS EC, PALS ST, VAN NOESEL CJ. Variable heavy chain gene analysis of follicular lymphomas: correlation between heavy chain isotype expression and somatic mutation load. Blood 2000;95:2922-2929.
32. HARDIANTI MS, TATSUMI E, SYAMPURNAWATI M, et al. Activation-induced cytidine deaminase expression in follicular lymphoma: association between AID expression and ongoing mutation in FL. Leukemia 2004;18:826-831.
33. DREXLER HG. The Leukemia-Lymphoma Cell Line Facts Book. London, UK: Academic Press, 2001.
34. TANIGUCHI M, OKA K, HIASA A, et al. De novo CD5 + diffuse large B-cell lymphomas express VH genes with somatic mutation. Blood 1998;91:1145-1151.
35. CERUTTI A, ZAN H, SCHAFFER A, BERGSAGEL L, HARINDRANATH N, MAX EE, CASALI P. CD40 ligand and appropriate cytokines induce switching to IgG, IgA, and IgE and coordinated germinal center and plasmacytoid phenotypic differentiation in a human monoclonal IgM + IgD + B cell line. J Immunol 1998;160:2145-2157.
36. DORNER T, FOSTER SJ, BREZINSCHEK HP, LIPSKY PE. Analysis of the targeting of the hypermutational machinery and the impact of subsequent selection on the distribution of nucleotide changes in human VHDJH rearrangements. Immunol Rev 1998;162:161-171.
37. NADLER LM, KORSMEYER SJ, ANDERSON KC, BOYD AW, SLAUGHENHOUPT B, PARK E, JENSEN J, CORAL F, MAYER RJ, SALLAN SE. B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation. J Clin Invest 1984;74:332-340.
38. MAGRATH IT, BHATIA K. Pathogenesis of small noncleaved cell lymphomas (Burkitt's lymphoma). In: MAGRATH IT, ed. The Non Hodgkin Lymphoma, 2nd edn. New York, NY: Oxford University Press, 1997:386-404.
39. HARDIANTI MS, TATSUMI E, SYAMPURNAWATI M, FURUTA K, SAIGO K, KAWANO S, KUMAGAI S, NAKAMURA F, MATSUO Y. Expression of activation-induced cytidine deaminase (AID) in Burkitt's lymphoma (BL) cells: rare A ID-negative cell lines with the unmutated rearranged VH gene. Leuk Lymphoma 2004;45:155-160.
40. NAVID F, MOSIJCZUK AD, HEAD DR, et al. Acute lymphoblastic leukemia with the (8;14)(q24;q32) translocation and FAB L3 morphology associated with a B-precursor immunophenotype: the Pediatric Oncology Group experience. Leukemia 1999;13:135-141.
41. FAILI A, AOUFOUCHI S, GUERANGER Q, ZOBER C, LEON A, BERTOCCI B, WEILL JC, REYNAUD CA. AID-dependent somatic hypermutation occurs as a DNA single-strand event in the BL2 cell line. Nat Immunol 2002;3:815-821.
42. ABBAS AK, LICHTMAN AH, POBER JS. Maturation, activation and regulation of lymphocytes. In: ABBAS AK, LICHTMAN AH, POBER JS, eds. Cellular and Molecular Immunology, 4th edn. Philadelphia, PA: W.B. Saunders, 2000:125-160.
43. BOUVET JP, BUFFE D, ORIOL R, LIACOPOULOS P. Two myeloma globulins IgG1-kappa and IgG1-lambda, from a single patient (Im). II. Their common cellular origin as revealed by immunofluorescence studies. Immunology 1974;27:1095-1101.
44. DEL SENNO L, GANDINI D, GAMBARI R, LANZA F, TOMASI P, CASTOLDI G. Monoclonal origin of B cells producing k, lambda and k lambda immunoglobulin light chains in a patient with chronic lymphocytic leukemia. Leuk Res 1987;11:1093-1098.
45. CHOI YJ, WONG MS. Double light-chain production by leukemic cells of common clonal origin: a case report with review of pertinent literature. Am J Hematol 1981;11:93-98.
46. GIACHINO C, PADOVAN E, LANZAVECCHIA A. kappa + lambda + dual receptor B cells are present in the human peripheral repertoire. J Exp Med 1995;181:1245-1250.
47. GOLLAHON KA, HAGMAN J, BRINSTER RL, STORB U. Ig lambda-producing B cells do not show feedback inhibition of gene rearrangement. J Immunol 1988;141:2771-2780.
48. MATSUO Y, NAKAMURA S, ARIYASU T, TERAO R, IMAJYO K, TSUBOTA T, KUWAHARA K, SAKAGUCHI N. Four subclones with distinct immunoglobulin light chain phenotypes. (kappa + lambda + , kappa + , lambda+ and kappa-lambda-) from acute leukemia. Leukemia 1996;10:700-706.
49. SMIT LA, BENDE RJ, ATEN J, GUIKEMA JE, AARTS WM, VAN NOESEL CJ. Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype. Cancer Res 2003;63:3894-3898.
50. JAFFE ES, HARRIS NL, STEIN H, VARDIMAN JW. World Health Organization Classification of Tumours. Pathology and Genetics of Hematopoietic and Lymphoid Tissues. France, Lyon: IARC Press, 2001.
51. BAHLER DW, CAMPBELL MJ, HART S, MILLER RA, LEVY S, LEVY R. IgVH gene expression among human follicular lymphomas. Blood 1991;78:1561-1568.
52. HEIGHT SE, SWANSBURY GJ, MATUTES E, TRELEAVEN JG, CATOVSKY D, DYER MJ. Analysis of clonal rearrangements of the Ig heavy chain locus in acute leukemia. Blood 1996;87:5242-5250.
53. MALOUM K, MAGNAC C, PRITSCH O, BINET JL, MERLEBERAL H, DIGHIERO G. Skewed rearrangement of the VH4-21 gene during pre-B acute Iymphoblastic leukemia. Leuk Lymphoma 1995;17:435-441.
54. BIRD J, GALILI N, LINK M, STITES D, SKLAR J. Continuing rearrangement but absence of somatic hypermutation in immunoglobulin genes of human B cell precursor leukemia. J Exp Med 1988;168:229-245.
55. VAN DER BURG M, BARENDREGT BH, VAN WERING ER, LANGERAK AW, SZCZEPANSKI T, VAN DONGEN JJ. The presence of somatic mutations in immunoglobulin genes of B cell acute Iymphoblastic leukemia (ALL-L3) supports assignment as Burkitt's leukemia-lymphoma rather than B-lineage ALL. Leukemia 2001;15:1141-1143.
56. BATANIAN JR, DUNPHY CH, RICHART JM, PETRUSKA PJ, PERKINS SL. Simultaneous presence of t(2;8)(p12;q24) and t(14;18)(q32;q21) in a B-cell lymphoproliferative disorder with features suggestive of an aggressive variant of splenic marginal-zone lymphoma. Cancer Genet Cytogenet 2000;120:136-140.
57. LOSSOS IS, OKADA CY, TIBSHIRANI R, et al. Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas. Blood 2000;95:1797-1803.
58. HUMMEL M, TAMARU J, KALVELAGE B, STEIN H. Mantle cell (previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood 1994;84:403-407.
59. TSUJIMOTO Y, GORHAM J, COSSMAN J, JAFFE E, CROCE CM. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 1985;229:1390-1393.
60. TSUJIMOTO Y, COSSMAN J, JAFFE E, CROCE CM. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985;228:1440-1443.
61. BAKHSHI A, WRIGHT JJ, GRANINGER W, et al. Mechanism of the t(14;18) chromosomal translocation: structural analysis of both derivative 14 and 18 reciprocal partners. Proc Natl Acad Sci USA 1987;84:2396-2400.
62. PRAK EL, WEIGERT M. Light chain replacement: a new model for antibody gene rearrangement. J Exp Med 1995;182:541-548.
63. HAN S, ZHENG B, SCHATZ DG, SPANOPOULOU E, KELSOE G. Neoteny in lymphocytes: Rag1 and Rag2 expression in germinal center B cells. Science 1996;274:2094-2097.
64. HIKIDA M, MORI M, TAKAI T, TOMOCHIKA K, HAMATANI K, OHMORI H. Reexpression of RAG-1 and RAG-2 genes in activated mature mouse B cells. Science 1996;274:2092-2094.
65. HAN S, DILLON SR, ZHENG B, SHIMODA M, SCHISSEL MS, KELSOE G. V(D)J recombinase activity in a subset of germinal center B lymphocytes. Science 1997;278:301-305.
66. NEMAZEE D, WEIGERT M. Revising B cell receptors. J Exp Med 2000;191:1813-1817.
67. KOBRIN C, BENDANDI M, KWAK L. Novel secondary Ig VH gene rearrangement and in-frame Ig heavy chain complementarity-determining region III insertion/deletion variants in de novo follicular lymphoma. J Immunol 2001;166:2235-2243.
68. JAGER U, BOCSKOR S, LE T, MITTERBAUER G, BOLZ I, CHOTT A, KNEBA M, MANNHALTER C, NADEL B. Follicular lymphomas' BCL-2/IgH junctions contain templated nucleotide insertions: novel insights into the mechanism of t(14;18) translocation. Blood 2000;95:3520-3529.
69. MARCULESCU R, LE T, BOCSKOR S, CHOTT A, MANNHALTER C, JAEGER U, NADEL B. Alternative end-joining in follicular lymphomas' t(14;18) translocation. Leukemia 2002;16:120-126.
70. AGRAWAL A, EASTMAN QM, SCHATZ DG. Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system. Nature 1998;394:744-751.
71. RAGHAVAN SC, SWANSON PC, Wu X, HSIEH CL, LIEBER MR. A non-B-DNA structure at the Bcl-2 major break-point region is cleaved by the RAG complex. Nature 2004;428:88-93.